Valeo Pharma (CSE: VPH) Commences YONDELIS® Commercialization in Canada
MONTREAL, QUEBEC , August 12, 2020 – Valeo Pharma Inc. (CSE:VPH, FSE:VP2) (“Valeo” or the “Company”), a Canadian specialty pharmaceutical company, announced today that it has commenced commercializing Yondelis® in Canada following the recently received […]
